IAVI, CureVac team up to accelerate AIDS vaccine development; GeoVax Ebola jab reports 100% protection in animal study;

> The International AIDS Vaccine Initiative (IAVI) is partnering with CureVac to accelerate the development of AIDS vaccines. Release

> GeoVax's Ebola vaccine posts 100% protection in guinea pigs and Syrian golden hamsters. More

> Walvax Biotechnology is using Medidata's ($MDSO) cloud-based platform to advance the development of a pediatric pneumococcal vaccine in China. Release

> Researchers at VIB and Ghent University in Belgium found a link between exposure to "farm dust" and protection against asthma and allergies. Release

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.